Science Explorer Back to mapMap
Discussion
Institution · Zuyderland Medisch Centrum

Most cited papers from Zuyderland Medisch Centrum

Zuyderland Medisch Centrum

What are the most cited papers from Zuyderland Medisch Centrum?

The most cited paper from Zuyderland Medisch Centrum is "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update" (Josef S Smolen et al., 2017), with 5,808 citations. Next come "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update" (2,807) and "Colchicine in Patients with Chronic Coronary Disease" (2,252).

Showing 50 of 60 papers. Every paper with more than 232 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access 6 Mar 2017 5,808
2 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access 22 Jan 2020 2,807
3 Colchicine in Patients with Chronic Coronary Disease Stefan Mark Nidorf et al. · New England Journal of Medicine Open access 31 Aug 2020 2,252
4 European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines Johannes Alfred Witjes, Harman Max Bruins, Richard L. Cathomas et al. · European Urology 29 Apr 2020 2,175
5 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access 10 Nov 2022 1,921
6 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis Désirée M F M van der Heijde et al. · Annals of the Rheumatic Diseases Open access 13 Jan 2017 1,593
7 ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update Sofía Ramiro et al. · Annals of the Rheumatic Diseases Open access 21 Oct 2022 994
8 Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study Philippe Moreau et al. · The Lancet Open access 3 Jun 2019 973
9 CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19—Definition and Evaluation Mathias Prokop, Wouter M. van Everdingen, Tjalco van Rees Vellinga et al. · Radiology Open access 27 Apr 2020 964
10 EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update Laure Gossec et al. · Annals of the Rheumatic Diseases Open access Jun 2020 960
11 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases Victoria Furer et al. · Annals of the Rheumatic Diseases Open access 14 Aug 2019 842
12 European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines Johannes Alfred Witjes et al. · European Urology Open access 17 Oct 2023 665
13 A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI Daniel M.F. Claassens, Gerrit J.A. Vos, Thomas O. Bergmeijer et al. · New England Journal of Medicine Open access 3 Sep 2019 649
14 2016 update of the EULAR recommendations for the management of early arthritis Bernard G Combe et al. · Annals of the Rheumatic Diseases Open access 10 Mar 2017 629
15 Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis et al. · European Urology 25 Sep 2018 581
16 Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma Maartje W. Rohaan et al. · New England Journal of Medicine Open access 7 Dec 2022 577
17 Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis J William L Brown et al. · JAMA Open access 15 Jan 2019 557
18 Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis Denise Aysel Yardley, Shinzaburo Noguchi, Kathleen I. Pritchard et al. · Advances in Therapy Open access Oct 2013 526
19 Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study Anna Hanxi He et al. · The Lancet Neurology Open access 18 Mar 2020 463
20 Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer Milou H. Martens, Monique Maas, Luc A. Heijnen et al. · JNCI Journal of the National Cancer Institute Open access 10 Aug 2016 431
21 Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation Jorn Brouwer et al. · New England Journal of Medicine Open access 30 Aug 2020 423
22 EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update Christian Dejaco et al. · Annals of the Rheumatic Diseases Open access 7 Aug 2023 381
23 Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies Ankie Reumkens, Eveline J. A. Rondagh, Minke C Bakker et al. · The American Journal of Gastroenterology Review 14 Jun 2016 374
24 Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis Sofía Ramiro, Alexandre Rocha Sepriano, Katerina Chatzidionysiou et al. · Annals of the Rheumatic Diseases ReviewOpen access 15 Mar 2017 373
25 Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial Désirée M F M van der Heijde et al. · The Lancet Open access 22 Oct 2018 372
26 Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial Marin J. de Jong, Andrea E. van der Meulen‐de Jong, Mariëlle J. L. Romberg-Camps et al. · The Lancet Open access 15 Jul 2017 369
27 Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial Cyriel Y. Ponsioen et al. · ˜The œLancet. Gastroenterology & hepatology 31 Aug 2017 368
28 Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease Constant V.M. Verschuur, Sven R. Suwijn, Judith A. Boel et al. · New England Journal of Medicine Open access 23 Jan 2019 361
29 Contrast-enhanced Mammography: State of the Art Maxine S. Jochelson, Marc B. I. Lobbes · Radiology Open access 2 Mar 2021 353
30 Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation Vincent Johan Nijenhuis et al. · New England Journal of Medicine Open access 29 Mar 2020 350
31 The enteric nervous system relays psychological stress to intestinal inflammation Kai Markus Schneider et al. · Cell Open access 25 May 2023 343
32 Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients Frances Humby et al. · Annals of the Rheumatic Diseases Open access 16 Mar 2019 340
33 Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study Bo Jan Noordman et al. · The Lancet Oncology Jun 2018 340
34 EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update Tuva Moseng et al. · Annals of the Rheumatic Diseases Open access 11 Jan 2024 320
35 Transforaminal lumbar interbody fusion (TLIF) versus posterior lumbar interbody fusion (PLIF) in lumbar spondylolisthesis: a systematic review and meta-analysis Suzanne L. de Kunder, Sander M. J. van Kuijk, Kim Rijkers et al. · The Spine Journal Review 22 Jun 2017 313
36 Deep Learning for Fully-Automated Localization and Segmentation of Rectal Cancer on Multiparametric MR Stefano Trebeschi, Joost J. M. van Griethuysen, Doenja M. J. Lambregts et al. · Scientific Reports Open access 7 Jul 2017 304
37 The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma Richard L. Cathomas, Anja Lorch, Harman Max Bruins et al. · European Urology 3 Nov 2021 301
38 Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study Daniëlle M. Gerlag, Mary Safy, Karen I. Maijer et al. · Annals of the Rheumatic Diseases Open access Dec 2018 294
39 Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study Ruben T. H. M. Larue, Janita E. van Timmeren, Evelyn E.C. de Jong et al. · Acta Oncologica Open access 8 Sep 2017 285
40 Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium Mark van den Boogaard et al. · JAMA Open access 20 Feb 2018 280
41 Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis Alexandre Rocha Sepriano, Andreas Kerschbaumer, Josef S Smolen et al. · Annals of the Rheumatic Diseases ReviewOpen access 7 Feb 2020 278
42 Smouldering multiple sclerosis: the ‘real MS’ Gavin Giovannoni, Veronica Popescu, Jens Thomas Wuerfel et al. · Therapeutic Advances in Neurological Disorders Open access 2022 275
43 Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis Jackie L Nam, Kaoru Takase-Minegishi, Sofía Ramiro et al. · Annals of the Rheumatic Diseases ReviewOpen access 10 Mar 2017 275
44 Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection – A Matched-Controlled Study Britt J. P. Hupkens, Milou H. Martens, Jan H.M.B. Stoot et al. · Diseases of the Colon & Rectum Open access 8 Sep 2017 275
45 EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 Robert Landewé, Pedro Machado, Féline P B Kroon et al. · Annals of the Rheumatic Diseases Open access 5 Jun 2020 264
46 Prediction of Stroke Risk by Detection of Hemorrhage in Carotid Plaques Andreas Schindler, Regina Schinner, N. Altaf et al. · JACC. Cardiovascular imaging Open access 12 Jun 2019 263
47 Surgery or embolization for varicoceles in subfertile men Anja CJ Kroese, Natascha M. de Lange, John A. Collins et al. · Cochrane Database of Systematic Reviews Open access 11 Oct 2012 261
48 Effect of Early Surgery vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis Yama Issa et al. · JAMA Open access 21 Jan 2020 261
49 TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort Christoph Molnar, Almut Scherer, Xenofon Baraliakos et al. · Annals of the Rheumatic Diseases Open access 23 Sep 2017 261
50 Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial Désirée M F M van der Heijde, Xenofon Baraliakos, Lianne S. Gensler et al. · The Lancet Open access 22 Oct 2018 258

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.